These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7615867)

  • 21. p53 and bcl-2 proteins as prognostic markers in human papillomavirus-associated cervical lesions.
    Kurvinen K; Syrjänen K; Syrjänen S
    J Clin Oncol; 1996 Jul; 14(7):2120-30. PubMed ID: 8683245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global burden of human papillomavirus and related diseases.
    Forman D; de Martel C; Lacey CJ; Soerjomataram I; Lortet-Tieulent J; Bruni L; Vignat J; Ferlay J; Bray F; Plummer M; Franceschi S
    Vaccine; 2012 Nov; 30 Suppl 5():F12-23. PubMed ID: 23199955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The advantage of a specialized HPV clinic within the department of proctology].
    Skala K; Zufferey G; Robert-Yap J; Morel P; Roche B
    Rev Med Suisse; 2011 Jun; 7(300):1348-50, 1352-3. PubMed ID: 21815534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoexpression of mutant p53 and human papillomavirus related E6 oncoprotein in anal malignancies.
    Gupta S; Sharma BK
    Indian J Exp Biol; 1998 Sep; 36(9):875-8. PubMed ID: 9854426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human papillomavirus-associated anogenital neoplasia in persons with HIV infection.
    Northfelt DW; Palefsky JM
    AIDS Clin Rev; 1992; ():241-59. PubMed ID: 1318737
    [No Abstract]   [Full Text] [Related]  

  • 26. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer.
    Pillai MR; Halabi S; McKalip A; Jayaprakash PG; Rajalekshmi TN; Nair MK; Herman B
    Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):329-35. PubMed ID: 9162297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of human papillomavirus and p53 tumor suppressor gene in cervical carcinogenesis.
    Kim KH; Kim YS
    Yonsei Med J; 1995 Nov; 36(5):412-25. PubMed ID: 8546000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human papillomavirus vaccines: WHO position paper, October 2014.
    Wkly Epidemiol Rec; 2014 Oct; 89(43):465-91. PubMed ID: 25346960
    [No Abstract]   [Full Text] [Related]  

  • 29. Papillomavirus and p53.
    zur Hausen H
    Nature; 1998 May; 393(6682):217. PubMed ID: 9607756
    [No Abstract]   [Full Text] [Related]  

  • 30. Human papillomaviruses and anogenital cancer.
    Vernon SD; Unger ER; Reeves WC
    N Engl J Med; 1998 Mar; 338(13):921-2. PubMed ID: 9518291
    [No Abstract]   [Full Text] [Related]  

  • 31. Aetiological parallel between tonsillar and anogenital squamous-cell carcinomas.
    Frisch M; Biggar RJ
    Lancet; 1999 Oct; 354(9188):1442-3. PubMed ID: 10543674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-localization of the tumor-suppressor protein p53 and human papillomavirus E6 protein in human cervical carcinoma cell lines.
    Liang XH; Volkmann M; Klein R; Herman B; Lockett SJ
    Oncogene; 1993 Oct; 8(10):2645-52. PubMed ID: 8397367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relation between retinoblastoma and p53 proteins in human papilloma viruses 16/18 positive and negative cancers of the uterine cervix.
    Chetty R; Bramdev A; Aguirre-Arteta A; Pegoraro RJ; Sataar N
    J Clin Pathol; 1997 May; 50(5):413-6. PubMed ID: 9215125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of p53 protein related to the presence of human papillomavirus (HPV) DNA in genital carcinomas and precancer lesions.
    Tervahauta AI; Syrjänen SM; Väyrynen M; Saastamoinen J; Syrjänen KJ
    Anticancer Res; 1993; 13(4):1107-11. PubMed ID: 8394670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Not Available].
    Torres-Román JS; Montenegro-Idrogo JJ
    Salud Publica Mex; 2017; 59(1):1-2. PubMed ID: 28423098
    [No Abstract]   [Full Text] [Related]  

  • 36. The case for a gender-neutral (universal) human papillomavirus vaccination policy in the United States: Point.
    Giuliano AR; Salmon D
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):805-8. PubMed ID: 18398020
    [No Abstract]   [Full Text] [Related]  

  • 37. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix.
    Uchiyama M; Iwasaka T; Matsuo N; Hachisuga T; Mori M; Sugimori H
    Gynecol Oncol; 1997 Apr; 65(1):23-9. PubMed ID: 9103386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer.
    Nelson RA; Lai LL
    Cancer; 2017 Oct; 123(20):4013-4021. PubMed ID: 28608917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of human cytomegalovirus in female and male anogenital lesions with papillomavirus-associated dysplastic changes.
    Mougin C; Bernard C; Schaal JP; Laurent R; Carbillet JP; Lab M
    Cancer Detect Prev; 1995; 19(4):316-24. PubMed ID: 7553673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p16, p14, p53, and cyclin D1 expression and HPV analysis in small cell carcinomas of the uterine cervix.
    Horn LC; Lindner K; Szepankiewicz G; Edelmann J; Hentschel B; Tannapfel A; Bilek K; Liebert UG; Richter CE; Einenkel J; Leo C
    Int J Gynecol Pathol; 2006 Apr; 25(2):182-6. PubMed ID: 16633070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.